GenesisCare drops Clarity Pharma stake, Wilsons on trade
Anthony Macdonald, Sarah Thompson and Kanika Sood
Feb 9, 2023 – 2.58pm
Debt-laden GenesisCare has sold its 6 per cent stake in biotech small cap Clarity Pharmaceuticals via Wilsons’ equities desk.
The block trade saw 15.36 million shares change hands at 72¢ each on Thursday, which was a 13 per cent discount to the stock’s last close at 83¢.
GenesisCare is expected to use the proceeds to help short up its finances.
It’s a small step for GenesisCare, which is investigating recapitalisation options in light of a $2 billion-plus debt profile and weak earnings. Ratings house S&P Global downgraded GenesisCare to “CCC-” on Wednesday, citing heightened risk of a default.
“Without a significant rebound in earnings or new equity, we view a distressed exchange or debt restructuring as being increasingly likely within the next six months,” S&P told clients this week.
While GenesisCare tries to find a path back to financial stability, it’s been seeking to sell its venture capital investments and real estate to ease the burden.
It owned a 6 per cent stake in Clarity via GenesisCare Ventures Pty Ltd.
Clarity is a clinical stage cancer biotech developing radiopharmaceutical products to image and diagnose cancers. It listed in August 2021 at $1.40 a share.
GenesisCare drops Clarity Pharma stake, Wilsons on trade Anthony...
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.25 |
Change
0.250(6.25%) |
Mkt cap ! $1.363B | |||
| Open | High | Low | Value | Volume |
| $4.04 | $4.25 | $4.04 | $6.228M | 1.493M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | $4.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.25 | 7933 | 2 |
View Market Depth
| Last trade - 16.10pm 27/12/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |
